COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Zomedica Corp. reports record year-over-year revenue for 18th straight quarter, with 14% growth in Q2 2025 driven by Diagnostic and Consumable segments -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets
Zomedica Corp. highlights groundbreaking tPEMF™ technology in veterinary care innovation webinar, featuring Assisi line products for pain and inflammation management in companion animals -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala
Zomedica Corp. announces strategic partnership with World Equestrian Center - Ocala for official shock wave therapy services, enhancing equine care and promoting veterinary health innovations
